| Item | Name | Cat. No. | Tag/Conjugates |
| Anti-SNCA/PARK1/PARK4 mAbs [Exidavnemab Biosimilar] (MABL-4693) | MABL-4693 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-PDL1/CD274 mAbs [Envafolimab Biosimilar] (MABL-4664) | MABL-4664 | ELISA, FACS, Functional assay, in vivo binding | G1, na |
| Anti-CCR8/CKR-L1/CDw198 mAbs [Enzelkitug Biosimilar] (MABL-4665) | MABL-4665 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-SIRPA mAbs [Epacmarstobart Biosimilar] (MABL-4666) | MABL-4666 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD3E;MS4A1/CD20 mAbs [Epcoritamab Biosimilar] (MABL-4667) | MABL-4667 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Lambda;Kappa |
| Anti-SIGLEC2/CD22 mAbs [Epratuzumab Biosimilar] (MABL-4668) | MABL-4668 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CALCA and CALCB mAbs [Eptinezumab Biosimilar] (MABL-4669) | MABL-4669 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-NCR3LG1/B7-H6;CD3E mAbs [Etuptamig Biosimilar] (MABL-4670) | MABL-4670 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Lambda |
| Anti-MS4A1/CD20 mAbs [Eramkafusp Biosimilar] (MABL-4671) | MABL-4671 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CALCRL mAbs [Erenumab Biosimilar] (MABL-4672) | MABL-4672 | ELISA, FACS, Functional assay, in vivo binding | G2, Lambda |
| Anti-PDL1/CD274;CTLA4/CD152 mAbs [Erfonrilimab Biosimilar] (MABL-4673) | MABL-4673 | ELISA, FACS, Functional assay, in vivo binding | G1, na;na |
| Anti-ITGB2/CD18 mAbs [Erlizumab Biosimilar] (MABL-4674) | MABL-4674 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-INSR/CD220 mAbs [Ersodetug Biosimilar] (MABL-4675) | MABL-4675 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-ENTPD1/CD39 mAbs [Emugrobart Biosimilar] (MABL-4649) | MABL-4649 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF1B/TNFR2/CD120b/TNFR80/p75 mAbs [Emunkitug Biosimilar] (MABL-4650) | MABL-4650 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-AXL/UFO mAbs [Enapotamab Biosimilar] (MABL-4651) | MABL-4651 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF12A/CD266/TWEAKR mAbs [Enavatuzumab Biosimilar] (MABL-4652) | MABL-4652 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-LAG3/CD223 mAbs [Encelimab Biosimilar] (MABL-4653) | MABL-4653 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-PVRL4/Nectin-4 mAbs [Enfortumab Biosimilar] (MABL-4654) | MABL-4654 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD19 mAbs [Englumafusp Biosimilar] (MABL-4655) | MABL-4655 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有
地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话:15339069646 邮箱:info@mabioway.cn
